OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Management of psychiatric disorders in Parkinson’s disease
Daniel Weintraub
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1511-1524
Open Access | Times Cited: 32
Daniel Weintraub
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1511-1524
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders
Javier Pagonabarraga, Cecilio Álamo, Mar Castellanos, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 318-318
Open Access | Times Cited: 20
Javier Pagonabarraga, Cecilio Álamo, Mar Castellanos, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 318-318
Open Access | Times Cited: 20
Impulse Control Disorders in Parkinson’s Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management
Federico Carbone, Atbin Djamshidian
CNS Drugs (2024) Vol. 38, Iss. 6, pp. 443-457
Open Access | Times Cited: 6
Federico Carbone, Atbin Djamshidian
CNS Drugs (2024) Vol. 38, Iss. 6, pp. 443-457
Open Access | Times Cited: 6
COVID-19 Pandemic and Psychiatric Symptoms: The Impact on Parkinson's Disease in the Elderly
Delfina Janiri, Martina Petracca, Lorenzo Moccia, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 44
Delfina Janiri, Martina Petracca, Lorenzo Moccia, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 44
Non-Pharmacological Interventions for Depression and Anxiety in Parkinson’s Disease
Erwin E. H. van Wegen, Tim D. van Balkom, Mark A. Hirsch, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s1, pp. S135-S146
Open Access | Times Cited: 5
Erwin E. H. van Wegen, Tim D. van Balkom, Mark A. Hirsch, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s1, pp. S135-S146
Open Access | Times Cited: 5
Neurotoxicity of Pyrethroids in neurodegenerative diseases: From animals' models to humans’ studies
Rafael Arsuffi-Marcon, Lizandra Gomes Souza, Artur Santos‐Miranda, et al.
Chemico-Biological Interactions (2024) Vol. 391, pp. 110911-110911
Closed Access | Times Cited: 4
Rafael Arsuffi-Marcon, Lizandra Gomes Souza, Artur Santos‐Miranda, et al.
Chemico-Biological Interactions (2024) Vol. 391, pp. 110911-110911
Closed Access | Times Cited: 4
Medical Applications of Silver and Gold Nanoparticles and Core‐Shell Nanostructures Based on Silver or Gold Core: Recent Progress and Innovations
Agata Kowalska, Elżbieta Adamska, Beata Grobelna
ChemMedChem (2024) Vol. 19, Iss. 12
Closed Access | Times Cited: 4
Agata Kowalska, Elżbieta Adamska, Beata Grobelna
ChemMedChem (2024) Vol. 19, Iss. 12
Closed Access | Times Cited: 4
Land- and water-based sports activities in natural environments as a group exercise for Parkinson’s disease: proof-of-concept pilot study
Martina Meloni, Davide Di Natale, Alessandra Caria, et al.
Sport Sciences for Health (2025)
Closed Access
Martina Meloni, Davide Di Natale, Alessandra Caria, et al.
Sport Sciences for Health (2025)
Closed Access
Potential Risk Factors for Psychosis in Parkinson’s Disease: A Review of Cohort and Case-Control Studies
Dimitry S. Davydow, Michael S. Okun, Gregory M. Pontone
Journal of Geriatric Psychiatry and Neurology (2025)
Closed Access
Dimitry S. Davydow, Michael S. Okun, Gregory M. Pontone
Journal of Geriatric Psychiatry and Neurology (2025)
Closed Access
Levodopa-synergistic CBT intervention improves Parkinson’s disease with anxiety disorder by regulating the BDNF/PI3K/AKT pathway
Niu Ji, Shanshan Lu, Bingchao Xu, et al.
Neurological Sciences (2025)
Open Access
Niu Ji, Shanshan Lu, Bingchao Xu, et al.
Neurological Sciences (2025)
Open Access
Impact of pimavanserin on prescribing practices in parkinson disease
Thanh Phuong Pham Nguyen, Vy Le, Daniel Weintraub, et al.
Clinical Parkinsonism & Related Disorders (2025), pp. 100317-100317
Open Access
Thanh Phuong Pham Nguyen, Vy Le, Daniel Weintraub, et al.
Clinical Parkinsonism & Related Disorders (2025), pp. 100317-100317
Open Access
Advances in the Pharmacological Management of Parkinson’s Disease
Derek G. Power, Grace F. Crotty
Current Treatment Options in Neurology (2025) Vol. 27, Iss. 1
Closed Access
Derek G. Power, Grace F. Crotty
Current Treatment Options in Neurology (2025) Vol. 27, Iss. 1
Closed Access
Impulse control and related behavioral disorders in Parkinson’s disease. Risk factors, diagnosis, and management. Is there a possible role for non-invasive brain stimulation?
Stefano Terruzzi, Lina Urh, Daniele Piscitelli, et al.
Neurological Sciences (2025)
Closed Access
Stefano Terruzzi, Lina Urh, Daniele Piscitelli, et al.
Neurological Sciences (2025)
Closed Access
Efficacy of a theatre-based intervention in patients with Parkinson’s disease
Marco Calabria, Francesco Ciongoli, Carmen García‐Sánchez, et al.
Arts & Health (2025), pp. 1-17
Open Access
Marco Calabria, Francesco Ciongoli, Carmen García‐Sánchez, et al.
Arts & Health (2025), pp. 1-17
Open Access
Focus on Depression in Parkinson’s Disease: A Delphi Consensus of Experts in Psychiatry, Neurology, and Geriatrics
Luis Agüera‐Ortiz, R. García-Ramos, Francisco J. Grandas Pérez, et al.
Parkinson s Disease (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 31
Luis Agüera‐Ortiz, R. García-Ramos, Francisco J. Grandas Pérez, et al.
Parkinson s Disease (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 31
Non-motor complications in late stage Parkinson’s disease: recognition, management and unmet needs
Katarina Rukavina, Lucia Batzu, Alexandra Boogers, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 3, pp. 335-352
Open Access | Times Cited: 29
Katarina Rukavina, Lucia Batzu, Alexandra Boogers, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 3, pp. 335-352
Open Access | Times Cited: 29
Efficacy of non-pharmacological interventions on depressive symptoms in patients with Parkinson’s disease: a study protocol for a systematic review and network meta-analysis
Xiaoyu Jiang, Linlin Zhang, Huifen Liu, et al.
BMJ Open (2023) Vol. 13, Iss. 5, pp. e068019-e068019
Open Access | Times Cited: 4
Xiaoyu Jiang, Linlin Zhang, Huifen Liu, et al.
BMJ Open (2023) Vol. 13, Iss. 5, pp. e068019-e068019
Open Access | Times Cited: 4
Atypical antipsychotic use and mortality risk in Parkinson disease
Thanh Phuong Pham Nguyen, Dylan Thibault, Ali G. Hamedani, et al.
Parkinsonism & Related Disorders (2022) Vol. 103, pp. 17-22
Open Access | Times Cited: 7
Thanh Phuong Pham Nguyen, Dylan Thibault, Ali G. Hamedani, et al.
Parkinsonism & Related Disorders (2022) Vol. 103, pp. 17-22
Open Access | Times Cited: 7
Depression After Parkinson’s Disease: Treated Differently or Not At All?
Elisabeth C. DeMarco, Zidong Zhang, Haider Al-Hakeem, et al.
Journal of Geriatric Psychiatry and Neurology (2022) Vol. 36, Iss. 1, pp. 39-51
Closed Access | Times Cited: 6
Elisabeth C. DeMarco, Zidong Zhang, Haider Al-Hakeem, et al.
Journal of Geriatric Psychiatry and Neurology (2022) Vol. 36, Iss. 1, pp. 39-51
Closed Access | Times Cited: 6
Management of Psychiatric Disorders in Patients with Parkinson’s Diseases
Adarsh Tripathi, Pawan Kumar Gupta, Teena Bansal
Indian Journal of Psychiatry (2022) Vol. 64, Iss. Suppl 2, pp. S330-S343
Open Access | Times Cited: 6
Adarsh Tripathi, Pawan Kumar Gupta, Teena Bansal
Indian Journal of Psychiatry (2022) Vol. 64, Iss. Suppl 2, pp. S330-S343
Open Access | Times Cited: 6
Pimavanserin: A Truly Effective Treatment for Parkinson’s Disease Psychosis? A Review of Interventions
Beatrice Heim, Marina Peball, Florian Krismer, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 1303-1312
Open Access | Times Cited: 3
Beatrice Heim, Marina Peball, Florian Krismer, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 1303-1312
Open Access | Times Cited: 3
Neuroticism, urbanization, and the state prevalence of Parkinson’s disease in the USA
Stewart J. H. McCann
Journal of Research in Personality (2022) Vol. 102, pp. 104319-104319
Closed Access | Times Cited: 5
Stewart J. H. McCann
Journal of Research in Personality (2022) Vol. 102, pp. 104319-104319
Closed Access | Times Cited: 5
Direct Medical Costs of Parkinson’s Disease in Southern China: A Cross-Sectional Study Based on Health Insurance Claims Data in Guangzhou City
Hui Zhang, Wenjing Zhou, Donglan Zhang
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 6, pp. 3238-3238
Open Access | Times Cited: 4
Hui Zhang, Wenjing Zhou, Donglan Zhang
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 6, pp. 3238-3238
Open Access | Times Cited: 4
Therapeutic Advances in Movement Disorders
Caroline M. Tanner, Jill L. Ostrem
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1325-1330
Open Access | Times Cited: 4
Caroline M. Tanner, Jill L. Ostrem
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1325-1330
Open Access | Times Cited: 4
Exploring relationships between state and trait anxiety and depression in patients with Parkinson’s disease and controls: a cross-sectional analysis
Elisabeth C. DeMarco, Jason K. Longhurst, Leslie Hinyard
Ageing and Neurodegenerative Diseases (2024) Vol. 4, Iss. 1
Open Access
Elisabeth C. DeMarco, Jason K. Longhurst, Leslie Hinyard
Ageing and Neurodegenerative Diseases (2024) Vol. 4, Iss. 1
Open Access
Parkinson’s Disease
Steven J. Frucht, Pichet Termsarasab
Springer eBooks (2024), pp. 11-87
Closed Access
Steven J. Frucht, Pichet Termsarasab
Springer eBooks (2024), pp. 11-87
Closed Access
